PharmAust subsidiary Epichem has entered into a joint venture deal to develop a “disruptive” waste-to-fuels technology using biomass and feedstock. Under the 50:50 agreement, medicinal and synthetic chemistry group Epichem and new JV partner Obsidian Minerals will set up the Perren company with the aim of developing and commercialising the biomass/feedstock oxidative hydrothermal dissolution chemical process that can turn waste into fuels.
02/09/2020 - 09:35
PharmAust subsidiary Epichem in waste-to-fuels tilt
By Matt Birney
02/09/2020 - 09:35
Related Data & Insights
-
-
Rank Company # 163rd I Synergy Group $1.14m 164th Zelira Therapeutics $1.02m 165th Singular Health $935.18k 166th PharmAust $841.71k 198 public companies - industrial WA ranked by total revenue
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
21 Jun 2024
PharmAust taps investors for $10m
31 May 2024
Shares rise following Thurn return
17 May 2024
Board Moves May 17, 2024
17 May 2024
PharmAust receives FDA approval
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024